These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8765695)

  • 1. Theoretical model of iontophoresis utilized in transdermal drug delivery.
    Ferry LL
    Pharm Acta Helv; 1995 Dec; 70(4):279-87. PubMed ID: 8765695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparative histology of porcine and guinea pig skin with respect to iontophoretic drug delivery.
    Ferry LL; Argentieri G; Lochner DH
    Pharm Acta Helv; 1995 Apr; 70(1):43-56. PubMed ID: 7770477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of appendages in skin resistance and iontophoretic peptide flux: human versus snake skin.
    Craane-van Hinsberg WH; Verhoef JC; Bax LJ; Junginger HE; Boddé HE
    Pharm Res; 1995 Oct; 12(10):1506-12. PubMed ID: 8584490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational and experimental model of transdermal iontophorethic drug delivery system.
    Filipovic N; Saveljic I; Rac V; Graells BO; Bijelic G
    Int J Pharm; 2017 Nov; 533(2):383-388. PubMed ID: 28576549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the cutaneous iontophoretic delivery of rasagiline and selegiline across porcine and human skin in vitro.
    Kalaria DR; Patel P; Patravale V; Kalia YN
    Int J Pharm; 2012 Nov; 438(1-2):202-8. PubMed ID: 22954444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iontophoretic delivery of ropinirole hydrochloride: effect of current density and vehicle formulation.
    Luzardo-Alvarez A; Delgado-Charro MB; Blanco-Méndez J
    Pharm Res; 2001 Dec; 18(12):1714-20. PubMed ID: 11785691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compartmental modeling of transdermal iontophoretic transport: I. In vitro model derivation and application.
    Nugroho AK; Della Pasqua O; Danhof M; Bouwstra JA
    Pharm Res; 2004 Nov; 21(11):1974-84. PubMed ID: 15587918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.
    Cázares-Delgadillo J; Naik A; Ganem-Rondero A; Quintanar-Guerrero D; Kalia YN
    Pharm Res; 2007 Jul; 24(7):1360-8. PubMed ID: 17457661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled transdermal delivery of leuprorelin by pulsed iontophoresis and ion-exchange fiber.
    Malinovskaja K; Laaksonen T; Hirvonen J
    Eur J Pharm Biopharm; 2014 Nov; 88(3):594-601. PubMed ID: 25173088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies.
    Cázares-Delgadillo J; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
    Eur J Pharm Sci; 2010 Mar; 39(5):387-93. PubMed ID: 20096354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal iontophoretic delivery of a liquid lipophilic drug by complexation with an anionic cyclodextrin.
    Juluri A; Narasimha Murthy S
    J Control Release; 2014 Sep; 189():11-8. PubMed ID: 24950431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal iontophoresis of dexamethasone sodium phosphate in vitro and in vivo: effect of experimental parameters and skin type on drug stability and transport kinetics.
    Cázares-Delgadillo J; Balaguer-Fernández C; Calatayud-Pascual A; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
    Eur J Pharm Biopharm; 2010 Jun; 75(2):173-8. PubMed ID: 20332024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
    Dubey S; Kalia YN
    J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iontophoretic transdermal delivery of sumatriptan: effect of current density and ionic strength.
    Femenía-Font A; Balaguer-Fernández C; Merino V; López-Castellano A
    J Pharm Sci; 2005 Oct; 94(10):2183-6. PubMed ID: 16136550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iontophoretic transdermal delivery of haloperidol.
    Alvarez-Figueroa MJ; Araya-Silva I; Díaz-Tobar C
    Pharm Dev Technol; 2006; 11(3):371-5. PubMed ID: 16895847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing iontophoretic drug delivery: identification and distribution of the charge-carrying species.
    Marro D; Kalia YN; Delgado-Charro MB; Guy RH
    Pharm Res; 2001 Dec; 18(12):1709-13. PubMed ID: 11785690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A linear theory of transdermal transport phenomena.
    Edwards DA; Langer R
    J Pharm Sci; 1994 Sep; 83(9):1315-34. PubMed ID: 7830250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive and iontophoretic transdermal penetration of chlorpromazine.
    Alvarez-Figueroa MJ; González-Aramundiz JV
    Pharm Dev Technol; 2008; 13(4):271-5. PubMed ID: 18649217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.